Tillotts Pharma Spain S.L.U.
SpainAll drugs from this manufacturer
-
It is used for the treatment of mild to moderate acute ulcerative colitis limited to the rectum (ulcerative proctitis). Its active ingredient, mesalazine, is an anti-inflammatory for inflammatory bowel disease.
Dosage form: suppositories
Active substance Dosage mesalazine 1 g -
It is used as an anti-inflammatory to treat ulcerative colitis, both in its acute phase (mild to moderate) and to maintain the disease under control (remission).
Dosage form: tablets, enteric-coated
Active substance Dosage mesalazine 1.600 mg -
It is used to treat the acute phase of mild to moderate ulcerative colitis and to maintain remission of this disease. It is also used to treat the acute phase and maintain remission of Crohn's disease.
Dosage form: tablets, enteric-coated
Active substance Dosage mesalazine 400 mg -
It is used to treat the acute phase of mild to moderate ulcerative colitis, for the maintenance of remission in ulcerative colitis, and for the maintenance of remission in Crohn's disease.
Dosage form: tablets, enteric-coated
Active substance Dosage mesalazine 800 mg